---
/**
 * Thesis Section 12: IPO Path
 * Public market exit path with inline citations
 */
import InlineCitation from '@components/citations/InlineCitation.astro';

interface Props {
  id?: string;
}

const { id = 'ipo-path' } = Astro.props;

// Citation data for IPO path statistics
const citations = {
  wellington: { index: 1, hexCode: 'ct5ss8', title: 'Biotech IPOs in 2025', url: 'https://www.wellington.com/en/insights/biotech-ipos-in-2025', source: 'Wellington Management', publishedDate: '2024-08-22' },
  patentpc: { index: 2, hexCode: 'kh56wu', title: 'Longevity Biotech Market Growth: How Fast Is Anti-Aging Science Advancing', url: 'https://patentpc.com/blog/longevity-biotech-market-growth-how-fast-is-anti-aging-science-advancing-new-stats', source: 'PatentPC', publishedDate: '2025-11-14' },
  crunchbase: { index: 3, hexCode: '2y30de', title: 'Longevity Startup Funding Sees Fewer Moonshots, But Plenty Of...', url: 'https://news.crunchbase.com/venture/longevity-startup-funding-2025-newlimit-data/', source: 'Crunchbase News', publishedDate: '2025-11-17' },
};
---

<section class="slide slide-ipo" id={id}>
  <div class="slide-gradient"></div>
  <div class="slide-content">
    <span class="badge badge-purple reveal-item" data-reveal="fade-up" style="--delay: 0ms;">Exit Paths</span>
    <h2 class="section-title reveal-item" data-reveal="fade-up" style="--delay: 100ms;">ðŸ“ˆ IPOs in Public Markets</h2>
    <p class="section-body reveal-item" data-reveal="fade-up" style="--delay: 200ms;">
      Biotech IPOs remain a core liquidity event, especially for companies with
      differentiated clinical data in age-related disease.
    </p>
    <div class="path-points">
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 300ms;">
        <h4>Quality Over Quantity</h4>
        <p>The post-2021 correction led to a disciplined IPO market focused on clinical-stage, de-risked assets.<InlineCitation {...citations.wellington} /></p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 400ms;">
        <h4>100% Clinical-Stage</h4>
        <p>By 2023, all US biotech IPOs had clinical-stage assets, with roughly one-third at Phase III.<InlineCitation {...citations.wellington} /></p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 500ms;">
        <h4>Mainstream Theme</h4>
        <p>Longevity-focused biotechs raised over $2 billion via IPOs in 2023 alone.<InlineCitation {...citations.patentpc} /></p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 600ms;">
        <h4>Data-Driven Stories</h4>
        <p>Investors reward platforms that pair bold aging biology with credible, near-term milestones.<InlineCitation {...citations.crunchbase} /></p>
      </div>
    </div>
  </div>
</section>

<style>
  .path-points {
    display: grid;
    grid-template-columns: repeat(2, 1fr);
    gap: 1.5rem;
  }

  @media (max-width: 768px) {
    .path-points {
      grid-template-columns: 1fr;
    }
  }

  .path-point {
    padding: 1.5rem;
    border-radius: 1rem;
  }

  .path-point h4 {
    font-size: 1rem;
    font-weight: 600;
    margin-bottom: 0.5rem;
  }

  .path-point p {
    font-size: 0.875rem;
    line-height: 1.5;
  }

  :global([data-mode="dark"]) .path-point {
    background: rgba(15, 9, 35, 0.8);
    border: 1px solid rgba(108, 99, 255, 0.15);
  }

  :global([data-mode="dark"]) .path-point h4 {
    color: var(--color-alabaster);
  }

  :global([data-mode="dark"]) .path-point p {
    color: rgba(249, 250, 251, 0.6);
  }
</style>
